Home › Funds › Euclidean Capital LLC › ALEC
Euclidean Capital LLC position in ALEC
ALECTOR INC COM · Health Care
Euclidean Capital LLC reported holding 1,307,858 shares of ALEC (ALECTOR INC COM) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.60% of its reported portfolio and ranking #8 among its reported holdings. Euclidean Capital LLC has disclosed ALEC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Euclidean Capital LLC's ALEC position evolved
Euclidean Capital LLC first disclosed a stake in ALEC in Q3 2023 at 1,307,858 shares (US$8.5M). The position peaked in Q4 2023 at 1,307,858 shares, worth US$10.4M. Across 12 filings, Euclidean Capital LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,307,858 shares valued at US$2.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.31M | $8.47M | New |
| Q4 2023 | 1.31M | $10.44M | Hold |
| Q1 2024 | 1.31M | $7.87M | Hold |
| Q2 2024 | 1.31M | $5.94M | Hold |
| Q3 2024 | 1.31M | $6.09M | Hold |
| Q4 2024 | 1.31M | $2.47M | Hold |
| Q1 2025 | 1.31M | $1.61M | Hold |
| Q2 2025 | 1.31M | $1.83M | Hold |
| Q3 2025 | 1.31M | $3.87M | Hold |
| Q4 2025 | 1.31M | $2.04M | Hold |
| Q1 2026 | 1.31M | $2.81M | Hold |
| Q2 2026 | 1.31M | $2.63M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALEC and 13F data
ALEC (ALECTOR INC COM) is a Health Care company. 30 other funds we track also report a position in ALEC — the largest reported positions include TCG Crossover Management, LLC (US$20.1M), Kynam Capital Management, LP (US$7.7M), Merck & Co., Inc. (US$7.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALEC
- TCG Crossover Management, LLC 10.00M sh · $20.10M · Q2 2026
- Kynam Capital Management, LP 3.81M sh · $7.66M · Q2 2026
- Merck & Co., Inc. 3.55M sh · $7.13M · Q2 2026
- Spruce Street Capital LP 2.10M sh · $4.22M · Q2 2026
- Ikarian Capital, LLC 1.98M sh · $3.99M · Q2 2026
- MEDICI CAPITAL LLC 1.65M sh · $3.32M · Q2 2026
More on Euclidean Capital LLC
FAQ
How long has Euclidean Capital LLC held ALEC?
Euclidean Capital LLC has disclosed ALEC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Euclidean Capital LLC's current position in ALEC?
As of Q2 2026, Euclidean Capital LLC holds 1.31M shares of ALEC (ALECTOR INC COM), valued at $2.63M, representing 0.60% of its reported portfolio and ranking #8.
Has Euclidean Capital LLC been buying or selling ALEC?
In the latest 13F filing (Q2 2026), Euclidean Capital LLC held unchanged its position in ALEC. The position peaked in Q4 2023 at 1.31M shares.
Which other funds hold ALEC?
Other major institutional holders of ALEC include TCG Crossover Management, LLC, Kynam Capital Management, LP, Merck & Co., Inc., among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.